过去一年中添加的文章,按日期排序
… (CONCORDE) phase Ib platform study of novel DNA damage response inhibitor (DDRi) agents in combination with radiotherapy in non-small cell lung cancer …
A Greystoke, JB Oughton, SR Brown, K Butterworth… - 2024 - ascopubs.org
39 天前 - … Background: Lung cancer is the leading cause of cancer mortality globally, with cases
… assess multiple DDRi in combination with radical thoracic RT (60Gy in 30 fractions over 6 …
… assess multiple DDRi in combination with radical thoracic RT (60Gy in 30 fractions over 6 …
… II trial of atezolizumab with or without tiragolumab before and after definitive chemoradiation for unresectable stage III non-small cell lung cancer (NSCLC; AFT-57).
39 天前 - TPS8123 Background: A minority of patients with unresectable stage III non-small
cell lung cancer (NSCLC) may be cured by chemoradiotherapy (CRT). Adjuvant checkpoint …
cell lung cancer (NSCLC) may be cured by chemoradiotherapy (CRT). Adjuvant checkpoint …
JCOG2002: A randomized phase III study of thoracic radiotherapy for extensive stage small cell lung cancer.
K Nosaki, Y Zenke, S Nomura, T Sasaki, S Niho, K Yoh… - 2024 - ascopubs.org
39 天前 - TPS8132 Background: Consolidative thoracic radiotherapy (cTRT) has shown a
marginal improvement in overall survival (OS) and progression-free survival (PFS) for extensive…
marginal improvement in overall survival (OS) and progression-free survival (PFS) for extensive…
… 1 trial: Pemetrexed-cisplatin plus bevacizumab or concurrent thoracic radiation therapy followed by surgery in stage IIIA (N2) nonsquamous non-small cell lung cancer …
K Takamochi, K Suzuki, M Tsuboi, S Niho, S Ishikura… - 2024 - ascopubs.org
39 天前 - … (BEV arm) or concurrent thoracic radiation therapy (TRT arm) followed by surgery
in patients with stage IIIA (N2) nonsquamous non-small cell lung cancer (NSCLC). The TRT …
in patients with stage IIIA (N2) nonsquamous non-small cell lung cancer (NSCLC). The TRT …
Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers.
Y Alwatari, M Shanshal, NC Johnson, V Thao… - 2024 - ascopubs.org
39 天前 - … -small cell lung cancers (NSCLC) and esophageal cancers (… and qualify for adjuvant
therapy (Stage IB – IIA with high-… of eligible operable thoracic malignancies could exceed …
therapy (Stage IB – IIA with high-… of eligible operable thoracic malignancies could exceed …
Double lung transplantation in patients with metastatic lung-limited non-small cell lung carcinoma (NSCLC): A case series.
YK Chae, T Demir, LILY Chung, W Woo, C Moloney… - 2024 - ascopubs.org
39 天前 - … in lung transplantation, lung cancer constituted less than 0.1% of the lung transplantation
… Results: Six patients with stage IVA NSCLC who underwent lung transplantation were …
… Results: Six patients with stage IVA NSCLC who underwent lung transplantation were …
… chemoradiotherapy and camrelizumab consolidation therapy versus standard chemoradiotherapy as first-line treatment for limited-disease small cell lung cancer.
X Yaping, J Ni, S Ren, X Xu, M Hu, Q Xu, Y Chen… - 2024 - ascopubs.org
39 天前 - … significant clinical benefits in extensive-stage small cell lung cancer (SCLC). However,
for … For thoracic radiation, 45 Gy in 3 weeks (1.5 Gy, BID) was given on the first day of the …
for … For thoracic radiation, 45 Gy in 3 weeks (1.5 Gy, BID) was given on the first day of the …
Lung cancer MDT quality assessment: A nationwide study.
J Berg, C Aamelfot, SG Aanes, M Wilskow… - 2024 - ascopubs.org
39 天前 - … , patients with lung cancer are discussed at local MDT (without a thoracic surgeon
… For 10 of the 12 there were differences in stage assessment, from stage IIIA-BC to IV, and in …
… For 10 of the 12 there were differences in stage assessment, from stage IIIA-BC to IV, and in …
CASTOR1 phosphorylation as a predictor of survival in male patients with KRAS-mutated lung adenocarcinoma.
39 天前 - … Background: Lung cancer, a leading global cause of cancer-related mortality, …
independent cohorts of patients who underwent thoracic surgical procedures at the University of …
independent cohorts of patients who underwent thoracic surgical procedures at the University of …
Overall survival of adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line treatment for extensive-stage small cell lung cancer.
D Chen, A Gao, B Zou, W Huang, Q Shao, X Meng… - 2024 - ascopubs.org
39 天前 - … (pts) with extensive-stage small cell lung cancer (ES-SCLC). … chemotherapy and
sequential thoracic radiotherapy (TRT) … Pts then entered the maintenance treatment stage with …
sequential thoracic radiotherapy (TRT) … Pts then entered the maintenance treatment stage with …